Xylem Inc. (NYSE:XYL) Shares Sold by Los Angeles Capital Management LLC

→ POTUS in ‘25 Not Biden/Trump, But (From The Freeport Society) (Ad)

Los Angeles Capital Management LLC lowered its stake in shares of Xylem Inc. (NYSE:XYL - Free Report) by 21.8% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 890,094 shares of the industrial products company's stock after selling 248,427 shares during the period. Los Angeles Capital Management LLC owned approximately 0.37% of Xylem worth $101,791,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Invesco Ltd. increased its position in Xylem by 35.1% during the third quarter. Invesco Ltd. now owns 4,182,821 shares of the industrial products company's stock valued at $380,762,000 after acquiring an additional 1,086,102 shares during the last quarter. American Century Companies Inc. increased its position in shares of Xylem by 66.8% during the 3rd quarter. American Century Companies Inc. now owns 2,159,710 shares of the industrial products company's stock valued at $196,598,000 after purchasing an additional 864,711 shares during the last quarter. AEGON ASSET MANAGEMENT UK Plc bought a new position in shares of Xylem in the 4th quarter worth approximately $74,297,000. Morgan Stanley boosted its holdings in shares of Xylem by 11.5% in the third quarter. Morgan Stanley now owns 4,528,905 shares of the industrial products company's stock worth $412,267,000 after buying an additional 466,911 shares during the last quarter. Finally, Robeco Schweiz AG grew its position in Xylem by 32.8% during the third quarter. Robeco Schweiz AG now owns 1,528,429 shares of the industrial products company's stock valued at $139,133,000 after buying an additional 377,748 shares during the period. Hedge funds and other institutional investors own 87.96% of the company's stock.


Wall Street Analyst Weigh In

Several research firms have weighed in on XYL. Royal Bank of Canada increased their price target on shares of Xylem from $140.00 to $145.00 and gave the stock an "outperform" rating in a research report on Wednesday, February 7th. Oppenheimer lifted their target price on Xylem from $133.00 to $142.00 and gave the company an "outperform" rating in a research report on Thursday, April 18th. Raymond James upgraded Xylem from an "underperform" rating to a "market perform" rating in a research report on Thursday, January 4th. BNP Paribas initiated coverage on Xylem in a research note on Tuesday, March 12th. They issued an "outperform" rating and a $150.00 price objective on the stock. Finally, Stifel Nicolaus boosted their price objective on Xylem from $136.00 to $150.00 and gave the company a "buy" rating in a research note on Wednesday, February 7th. Four analysts have rated the stock with a hold rating and eight have given a buy rating to the company's stock. According to MarketBeat, Xylem has a consensus rating of "Moderate Buy" and a consensus target price of $138.11.

View Our Latest Report on XYL

Xylem Price Performance

Shares of Xylem stock traded up $5.03 on Thursday, hitting $135.99. 2,782,034 shares of the company traded hands, compared to its average volume of 1,184,620. Xylem Inc. has a 52 week low of $87.59 and a 52 week high of $137.18. The business has a 50-day simple moving average of $128.19 and a 200 day simple moving average of $114.74. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.30 and a current ratio of 1.76. The stock has a market capitalization of $32.96 billion, a P/E ratio of 49.85, a price-to-earnings-growth ratio of 2.60 and a beta of 1.08.

Xylem (NYSE:XYL - Get Free Report) last announced its quarterly earnings results on Thursday, May 2nd. The industrial products company reported $0.90 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.84 by $0.06. The company had revenue of $2.03 billion for the quarter, compared to the consensus estimate of $2 billion. Xylem had a net margin of 8.27% and a return on equity of 9.65%. Xylem's revenue for the quarter was up 40.4% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.72 EPS. Research analysts expect that Xylem Inc. will post 4.13 earnings per share for the current fiscal year.

Xylem Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, March 20th. Investors of record on Wednesday, February 21st were paid a dividend of $0.36 per share. The ex-dividend date was Tuesday, February 20th. This is a positive change from Xylem's previous quarterly dividend of $0.33. This represents a $1.44 dividend on an annualized basis and a yield of 1.06%. Xylem's dividend payout ratio is presently 52.94%.

Insider Buying and Selling at Xylem

In other news, CAO Geri-Michelle Mcshane sold 1,000 shares of the company's stock in a transaction that occurred on Tuesday, February 20th. The stock was sold at an average price of $122.89, for a total transaction of $122,890.00. Following the sale, the chief accounting officer now directly owns 2,935 shares of the company's stock, valued at approximately $360,682.15. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, SVP Franz Cerwinka sold 2,408 shares of Xylem stock in a transaction dated Thursday, February 8th. The stock was sold at an average price of $121.79, for a total value of $293,270.32. Following the completion of the transaction, the senior vice president now owns 11,750 shares in the company, valued at $1,431,032.50. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CAO Geri-Michelle Mcshane sold 1,000 shares of the company's stock in a transaction that occurred on Tuesday, February 20th. The shares were sold at an average price of $122.89, for a total value of $122,890.00. Following the sale, the chief accounting officer now owns 2,935 shares in the company, valued at $360,682.15. The disclosure for this sale can be found here. 0.27% of the stock is currently owned by company insiders.

Xylem Profile

(Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

Featured Stories

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Should you invest $1,000 in Xylem right now?

Before you consider Xylem, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.

While Xylem currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Featured Articles and Offers

Search Headlines: